Journal Information
Most cited
72
Clinical treatment of cholangiocarcinoma: an updated comprehensive reviewAlessandra Elvevi, Alice Laffusa, Miki Scaravaglio, Roberta Elisa Rossi, Raffaella Longarini, Anna Maria Stagno, Laura Cristoferi, Antonio Ciaccio, ... Sara Massironi
Ann Hepatol. 2022;27:100737
72
Open access
46
From Child-Pugh to MELD score and beyond: Taking a walk down memory laneAndres Ruf, Melisa Dirchwolf, Richard B. Freeman
Ann Hepatol. 2022;27:100535
46
Open access
42
Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and CPegah Golabi, James M. Paik, Katherine Eberly, Leyla de Avila, Saleh A. Alqahtani, Zobair M. Younossi
Ann Hepatol. 2022;27:100556
42
Open access
33
The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based studyOsama Hamid, Ahmed Eltelbany, Abdul Mohammed, Khaled Alsabbagh Alchirazi, Sushrut Trakroo, Imad Asaad
Ann Hepatol. 2022;27:100727
33
Open access
26
Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathwaySi-Si Jin, Chun-Jing Lin, Xian-Fan Lin, Ju-Zeng Zheng, Hua-Qin Guan
Ann Hepatol. 2022;27:100584
26
Open access
25
Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysisYesmi A. Ortega Rojas, Claudia L. Vidal Cuellar, Karina M. Aparicio Barrón, Juan Pablo Arab, Adelina Lozano Miranda
Ann Hepatol. 2022;27:100706
25
Full text access
22
NAFLD VS MAFLD. The evidence-based debate has come. Time to change?Diego García-Compeán, Alan Rafael Jiménez-Rodríguez
Ann Hepatol. 2022;27:100765
22
Full text access
22
Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathwaysEduardo E. Vargas-Pozada, Erika Ramos-Tovar, Consuelo Acero-Hernández, Irina Cardoso-Lezama, Silvia Galindo-Gómez, Víctor Tsutsumi, Pablo Muriel
Ann Hepatol. 2022;27:100671
22
Open access
21
miR-221-3p regulates hepatocellular carcinoma cell proliferation, migration and invasion via targeting LIFRWei Tan, Zhuokai Li, Weifen Xia, Jinde Zhu, Rengen Fan
Ann Hepatol. 2022;27 Supl 1:100567
21
Open access
20
Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomyTianyi Liang, Yongfei He, Shutian Mo, Zijun Chen, Xiwen Liao, Xin Zhou, Chengkun Yang, Shuqi Zhao, ... Tao Peng
Ann Hepatol. 2022;27:100695
20
Open access